New wave of cancer screening announced to boost early diagnoses

Nov 23, 2017

NHS England has announced it is expanding schemes to improve early cancer diagnosis rates. Detecting cancer in its early stages increases chances of survival and leads to better quality of life in the patient population as a whole.

This will focus on three types of cancer - lung, bowel and prostate. Lung cancer, in particular, kills more people in the UK than any other cancer, and each year around 46,000 new cases are diagnosed.

Siemens Healthineers is passionate about the beneficial use of low radiation dose CT scanning to improve patient survival through earlier detection of cancer. Siemens CT scanners have now established a new standard in low radiation dose technology and dose has become a key consideration in scanning equipment selection for lung cancer screening.

NHS England succeeded with its pilot mobile scanner scheme in Manchester where mobile stations offered free health checks and on-the-spot low dose CT scans to smokers and ex-smokers and quadrupled the early diagnosis rates for lung cancer in the area. The figures from NHS England show that more than 2,500 people in three deprived areas of Manchester were scanned and of the 46 cases of cancer discovered, 80% were early stage one and two diagnoses.

Siemens Healthineers' latest ultra low dose CT scanners are capable of reducing dose by up to 50% in lung and colon exams and set new benchmarks in the examination of high-risk, asymptomatic patients. The systems offer a range of features that simplify the scanning process, meaning the staff can fully focus on the patient.

Ensuring each cancer patient gets the right care for them is crucial. With scanners that allow faster preparation, reduce the length of examinations and the potential number of recalls, Siemens Healthineers is promoting better cancer patient care.

These new low radiation dose CT scanners are currently being adapted so they can be used in mobile stations that can stand in supermarket car parks. They will be available early next year.